Durham-based Atsena Therapeutics has raised $150 million to advance gene therapies for preventing or reversing types of ...

Liquidia's collaboration with Sandoz and development of new products like L606 show promise. Learn why LQDA stock is a Hold.

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...